Physiological and Pathological Androgen Actions in the Ovary

• Published in: Endocrinology (Philadelphia) Vol. 160; no. 5; pp. 1166 - 1174
• Main Authors: Astapova, Olga, Minor, Briaunna M N, Hammes, Stephen R
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 01-05-2019; Endocrine Society
• Subjects: Androgen receptors; Androgens; Androgens - metabolism; Animal models; Animals; Development and progression; Endocrinology; Female; Gametocytes; Gene Expression; Genetic aspects; Granulosa cells; Granulosa Cells - metabolism; Humans; Infertility; Male identity; Medical research; Mice, Knockout; Mini-Review; Oocytes; Ovarian diseases; Ovarian Follicle - metabolism; Ovulation; Physiological aspects; Polycystic ovary syndrome; Pregnant women; Receptors, Androgen - genetics; Receptors, Androgen - metabolism; Reproduction; Reproduction (biology); Reproductive health; Reproductive system; Sex hormones; Steroid hormones; Steroidogenesis; Steroids; Theca; Theca Cells - metabolism; Women's health; United States
• ISSN: 1945-7170; 0013-7227; 1945-7170
• DOI: 10.1210/en.2019-00101

Androgens, although traditionally thought to be male sex steroids, play important roles in female reproduction, both in healthy and pathological states. This mini-review focuses on recent advances in our knowledge of the role of androgens in the ovary. Androgen receptor (AR) is expressed in oocytes, granulosa cells, and theca cells, and is temporally regulated during follicular development. Mouse knockout studies have shown that AR expression in granulosa cells is critical for normal follicular development and subsequent ovulation. In addition, androgens are involved in regulating dynamic changes in ovarian steroidogenesis that are critical for normal cycling. Androgen effects on follicle development have been incorporated into clinical practice in women with diminished ovarian reserve, albeit with limited success in available literature. At the other extreme, androgen excess leads to disordered follicle development and anovulatory infertility known as polycystic ovary syndrome (PCOS), with studies suggesting that theca cell AR may mediate many of these negative effects. Finally, both prenatal and postnatal animal models of androgen excess have been developed and are being used to study the pathophysiology of PCOS both within the ovary and with regard to overall metabolic health. Taken together, current scientific consensus is that a careful balance of androgen activity in the ovary is necessary for reproductive health in women.